Assessing the Impact of a Telemedicine Program on Caregivers of Children With Complex Chronic Conditions: Pre-Post Intervention Study.

Publication date: May 20, 2025

The COVID-19 pandemic was a paradigm shift in global health care. This situation highlighted the role of telemedicine in adapting to the care requirements of pediatric patients and their families by facilitating remote consultations and ensuring continuity of care. We aimed to establish the usefulness of a telemedicine program for caregivers of children with complex chronic conditions. We performed a quasi-experimental pre-post intervention study of a telemedicine program, regarding health care system use and caregiver quality of life while comparing two periods: before and during the COVID-19 pandemic. This study included caregivers of children with complex chronic conditions followed-up in a specialized unit. A total of 34 families were included. The mean number of visits per year was higher in the preintervention period for both primary care consultations (P=. 03) and hospital-specialized medical consultations (P=. 03). The number of emergency room visits per year was lower in the pandemic period compared to the prepandemic period (P=. 01). In both groups, an improvement in caregiver quality of life was detected at 12 months (P=. 03). However, the Rosenberg self-esteem scale score for the primary caregiver was significantly lower at 3 months compared to the baseline (P=. 03). Our study demonstrates that the use of a telemedicine program resulted in decreased scheduled face-to-face care visits and a reduction in the number of emergency department visits. Regarding the caregiver quality of life, outcomes were poorer among families whose children were affected by neurological conditions or were diagnosed at an older age.

Open Access PDF

Concepts Keywords
Hospital caregivers
Months children
Pandemic chronic
Parent complex chronic children
Usefulness COVID-19
global health
palliative care
pandemic
pediatrics
primary care
quality of life
quasi-experimental
remote consultation
SARS-Cov-2
telehealth
telemedicine

Semantics

Type Source Name
disease MESH Chronic Conditions
disease IDO intervention
disease MESH COVID-19 pandemic
disease IDO role
disease IDO quality
disease MESH emergency
drug DRUGBANK Coenzyme M
disease MESH cancer
disease MESH complications
disease MESH infection
disease MESH medication errors
disease IDO algorithm
drug DRUGBANK Pirenzepine
drug DRUGBANK Methyltestosterone
drug DRUGBANK Oxygen
disease IDO country
disease MESH Caregiver Burden
drug DRUGBANK Ademetionine

Original Article

(Visited 1 times, 1 visits today)